Clinical Trial Update: Phase III Study of a Topical Gel Formulation for Treatment and Prevention of Raynaud's Phenomenon [Phase 3]

View source ↗

Summary

A Phase III trial evaluating a topical gel for treatment and prevention of Raynaud's phenomenon has completed, including participants with Raynaud's phenomenon …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Raynaud Phenomenon
• Systemic Sclerosis

Snippet

Sponsor: MediQuest Therapeutics | Conditions: Raynaud's Disease, Scleroderma | Phase 3 | Status: COMPLETED